RYPLAZIM 68.8mg (Plasminogen, Human Tymh)

Stony Brook University Hospital Receiving, 101 Nicolls Road, Stony Brook, New York 11794

Stony Brook University Hospital intends to purchase Rylpazim (Plasminogen, Human Tymh) manufactured by Kedrion and Distributed by FFF Enterprises Inc. under its discretionary authority, pursuant to NYS Education Law §355(5)(A), which is up to $125,000, for the above noted commodity/product or service. A sealed bid will not be held. If you are interested in providing a proposal for the above commodity/product or service, you must contact the appropriately designated Campus contact in this advertisement within 15 business days of this Advertisement Notice.

This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law. Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below. Failure to comply with this requirement can range from no contract to debarment from sales to any NYS Agency. Successful contractor shall be required to complete and submit documents related to Vendor Responsibility, NYS Finance Law 139, NYS Tax Law Section 5-a, and valid/current NYS Workers’ Compensation and Disability Forms.